The short-term changes of bone mineral metabolism following bone marrow transplantation

Bone

Volumn 26, Issue 3, 2000, Pages 275-279

  Kang, M I ^a   Lee, W Y ^a   Oh, K W ^a   Han, J H ^a   Song, K H ^a   Cha, B Y ^a   Lee, K W ^a   Son, H Y ^a   Kang, S K ^a   Kim, C C ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Biochemical turnover markers; Bone loss; Bone marrow transplantation; Bone mineral density; Menopause; Total body irradiation

Indexed keywords

BIOCHEMICAL MARKER; CALCIUM; COLLAGEN TYPE 1; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ESTRADIOL; GONADOTROPIN; METHYLPREDNISOLONE; OSTEOCALCIN; PHOSPHORUS; PREDNISOLONE; TESTOSTERONE;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; AMENORRHEA; APLASTIC ANEMIA; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLOOD LEVEL; BONE ATROPHY; BONE MARROW TRANSPLANTATION; BONE METABOLISM; BONE MINERAL; CLINICAL ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; FEMALE; FEMUR; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HUMAN; HUMAN TISSUE; LEUKEMIA; LUMBAR SPINE; MALE; MYELODYSPLASTIC SYNDROME; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE MARROW TRANSPLANTATION; FEMALE; HEMATOLOGIC DISEASES; HUMANS; MALE; MIDDLE AGED; MINERALS; PROSPECTIVE STUDIES;

EID: 0033956271     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(99)00265-3     Document Type: Article

References (21)

1. Arnold J.C., Hauser D., Ziegler R., Kommerell B., Otto G., Theilmann L., Wuster C. Bone disease after liver transplantation. Transplant Proc. 24:1992;2709-2710.
2. Aubia J., Masramon J., Serrano S., Lioveras J., Marinoso L.L. Bone histology in renal transplant patients receiving cyclosporin. Lancet I. 1988;1048-1049.
3. Benker G., Schafer U., Hermanns U., Mahmoud M.K., Olbricht T., Schulte H.M., Windeck R., Reinwein D. Allogeneic bone marrow transplantation in adults endocrine sequelae after 1-6 years . Acta Endocrinol. 120:1989;37-42.
4. Bertolini D.R., Nedwin G.E., Bringman T.S., Smith D.D., Mundy G.R. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factor. Nature. 319:1986;516-518.
5. Bhatia S., Ramsay N.K.C., Weisdorf D., Griffiths H., Robison L.L. Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies. Bone Marrow Transplant. 22:1998;87-90.
6. Boot A.M., Nauta J., Hokken-Koelega A.C.S., Pols H.A.P., Ridder M.A.J., Keizer-Schrama S. Renal transplantation and osteoporosis. Arch Dis Child. 72:1995;502-506.
7. Canalis E. Mechanisms of glucocorticoid action in bone implications to glucocorticoid-induced osteoporosis . J Clin Endocrinol Metab. 81:1996;3441-3447.
8. Carlson K., Simonsson B., Ljunghall S. Acute effects of high-dose chemotherapy followed by bone marrow transplantation on serum markers of bone metabolism. Calcif Tissue Int. 55:1994;408-411.
9. Castaneda S., Carmona L., Carvajal I., Arranz R., Diaz A., Garcia-Vadillo A. Reduction of bone mass in women after bone marrow transplantation. Calcif Tissue Int. 60:1997;343-347.
10. Grotz W.H., Mundinger F.A., Gugel B., Exner V.M., Kirste G., Schollmeyer P.J. Bone mineral density after kidney transplantation. Transplantation. 59:1995;982-986.
11. Heimpel H., Arnold R., Hetzel W.D., Hueske D., Kreuser E.D., Wirthensohn E.F., Voss A.C., Slanina J. Gonadal function after bone marrow transplantation in adult male and female patients. Bone Marrow Transplant. 8:1991;21-24.
12. Ishida Y., Heersche J.N.M. Glucocorticoid-induced osteoporosis both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation . J Bone Miner Res. 13:1998;1822-1826.
13. Julian B.A., Lascow D.A., Dubovsky J., Dubovsky E.V., Curtis J.J., Quarles L.D. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med. 325:1992;544-550.
14. Keilholz U., Max R., Scheibenbogen C., Wuster C., Korbling M., Haas R. Endocrine function and bone metabolism 5 years after autologous bone marrow/blood-derived progenitor cell transplantation. Cancer. 79:1997;1617-1622.
15. Kelly P.Z., Atkinson K., Ward R.L., Sambrook P.N., Biggs J.C., Eisman J.A. Reduced bone mineral density in men and women with allogeneic bone marrow transplantation. Transplantation. 50:1990;881-882.
16. Lee A.H., Mull R.L., Keenan G.F., Callegari P.E., Dalinka M.K., Eisen H.J., Mancini D.M., Disesa V.J., Attie M.F. Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med. 96:1994;35-41.
17. Reid I.R., Chapman G.E., Fraser T.R.C., Davies A.D., Surus A.S., Meyer J., Huq N.L., Ibbertson H.K. Low serum osteocalcin levels in glucocorticoid-treated asthmatics. J Clin Endocrinol Metab. 62:1986;379-383.
18. Schimmer A.D., Quatermain M., Imrie K., Ali V., McCrae J., Stewart A.K., Crump M., Derzko C., Keating A. Ovarian function after autologous bone marrow transplantation. J Clin Oncol. 16:1998;2359-2363.
19. Shane E., Rivas M., McMahon D.J., Staron R.B., Silverberg S.J., Seibel M.J., Mancini D., Michler R.E., Aaronson K., Addesso V., Lo S.H. Bone loss and turnover after cardiac transplantation. J Clin Endocrinol Metab. 82:1997;1497-1506.
20. Stashenko P., Dewhirst F.E., Rooney M.L., Desjardins L.A., Hecley J.D. Interleukin-1 β is a potent inhibitor of bone formation in vitro. J Bone Miner Res. 2:1987;559-565.
21. Stern J.M., Chesnut C.H. III, Bruemmer B., Sullivan K.M., Lenssen P.S., Aker S.N., Sanders J. Bone density loss during treatment of chronic GVHD. Bone Marrow Transplant. 17:1996;395-400.